Ipca Laboratories Ltd

  • BSE Code : 524494
  • NSE Symbol : IPCALAB
  • ISIN : INE571A01038
  • Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

up-arrow 1,389.80 58.10(4.36%)

Open Price ()

1,344.50

Prev. Close ()

1,331.70

Volume (No’s)

335,012

Market Cap ()

33,785.79

Low Price ()

1,331.70

High Price ()

1,397.00

 

Book Closure

From Date To Date Announcement
05-Aug-2025 NA The Company has fixed Tuesday, 5th August, 2025 as the Record Date for the Members entitlement of final dividend, if it is approved at the ensuing Annual General Meeting.
29-May-2025 NA Ipca Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 inter alia to consider and approve Standalone & Consolidated Audited Financial Results for the 4th Quarter and FY25 and recommendation of final dividend for FY 24-25 Board Meeting Outcome for Standalone And Consolidated Audited Financial Results For Q4FY25 Standalone and Consolidated Audited Financial Results for Q4FY25 Amendment to Memorandum of Association (As Per BSE Announcement Dated on: 29/05/2025)
31-Mar-2025 NA We also wish to inform you that, the Board has declared an interim dividend of Rs. 21- per equity share of Re. 1/- each (200%) for the financial year 2024-25 Kindly note that vide our letter dated October 28, 2024, we have already informed you that 25lh November, 2024 has been fixed as the Record Date for ascertaining the members entitlement of interim dividend now declared which will be paid by the Company to the eligible shareholders on or before 10th December, 2024. Further to our letter dated 28th October, 2024 and in view of the email received from BSE Ltd., we now wish to inform you that the Company has decided to revise the Record Date' as Wednesday, 27th November, 2024 for the Members entitlement of interim dividend for the financial year 2024-25 that was declared at the Meeting of the Board of Directors of the Company held on 14th November, 2024. (As per BSE Announcement Dated on 18/11/2024)
31-Mar-2025 NA The Board has recommended a final dividend of Rs. 2/- per share (200%) for the financial year ended 31s1 March, 2025.
28-Mar-2025 NA Outcome of Board Meeting - 28.03.2025

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew